These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12640303)
1. Long-term limb allograft survival using anti-CD40L antibody in a murine model. Tung TH; Mackinnon SE; Mohanakumar T Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303 [TBL] [Abstract][Full Text] [Related]
2. Costimulation blockade of CD40 and CD28 pathways in limb transplantation. Tung TH; Mackinnon SE; Mohanakumar T Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474 [TBL] [Abstract][Full Text] [Related]
3. Prolonged limb allograft survival with CD 40 costimulation blockade, T-cell depletion, and megadose donor bone-marrow transfusion. Tung TH; Mackinnon SE; Mohanakumar T Microsurgery; 2005; 25(8):624-31. PubMed ID: 16281278 [TBL] [Abstract][Full Text] [Related]
4. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts. Brenner MJ; Tung TH; Mackinnon SE; Myckatyn TM; Hunter DA; Mohanakumar T Exp Neurol; 2004 Mar; 186(1):59-69. PubMed ID: 14980810 [TBL] [Abstract][Full Text] [Related]
5. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model. Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776 [TBL] [Abstract][Full Text] [Related]
6. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies. Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569 [TBL] [Abstract][Full Text] [Related]
7. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445 [TBL] [Abstract][Full Text] [Related]
8. Control of intestinal allograft rejection by FTY720 and costimulation blockade. Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565 [TBL] [Abstract][Full Text] [Related]
9. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway. Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518 [TBL] [Abstract][Full Text] [Related]
10. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
11. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation. Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow. Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779 [TBL] [Abstract][Full Text] [Related]
14. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Qian Y; Boisgerault F; Benichou G; Dana MR Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623 [TBL] [Abstract][Full Text] [Related]
16. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246 [TBL] [Abstract][Full Text] [Related]
17. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model. Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190 [TBL] [Abstract][Full Text] [Related]
18. [Experimental study on induction of skin allograft tolerance in mice by heat shock protein 60]. Huang W; Ye Q; Huang Z; Yang D; Peng M Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):993-7. PubMed ID: 18773821 [TBL] [Abstract][Full Text] [Related]
19. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
20. Tolerance induction through megadose bone marrow transplantation with two-signal blockade. Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]